Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ATG16L1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ATG16L1 is a gene implicated in neurodegeneration research. Key relationships include: interacts with, activates, regulates. Associated with ALS, Aging, Als. Connected to 389 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | ATG16L1 |
| Chromosome | 2q37.1 |
| Function | is a core autophagy protein essential for autophagosome formation and cellular protein quality control. |
| Primary Expression | neurons and glial cells throughout the brain, including the cortex, [hippocam |
| Subcellular Localization | </th><td>Autophagosome membrane, Cytoplasm</td></tr> |
| Amino Acids | 607 aa |
| Pathways | Akt, Autophagy, Epigenetic, Mapk, Mtor |
| Ensembl ID | ENSG00000085978 |
| GeneCards | ATG16L1 |
| Human Protein Atlas | ATG16L1 |
| Coiled-Coil Domain (residues 150–300) | Important for homodimerization of ATG16L1. The dimerized form creates a multivalent platform that enhances ATG5 binding. |
| Mitophagy | ATG16L1 helps target damaged mitochondria for autophagic degradation through interactions with autophagy receptors like p62/SQSTM1 and OPTN. |
| Aggrephagy | The protein participates in the clearance of protein aggregates, which is particularly important in neurodegenerative diseases. |
| Xenophagy | ATG16L1 contributes to the degradation of intracellular pathogens. |
| Synaptic Protein Turnover | Autophagy regulates synaptic protein composition and function at presynaptic and postsynaptic terminals. |
| Associated Diseases | Inflammation, Intestinal Disease, Osteoarthritis, Parkinson, Rheumatoid Arthritis, Tumor |
| Known Drugs/Compounds | rapamycin |
| Interactions | ABP, AIM2, AKT, AKT1, ALZHEIMER, ALZHEIMER'S DISEASE |
| KG Connections | 559 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
ATG16L1["ATG16L1"] -->|"regulates"| autophagy["autophagy"]
ATG16L1["ATG16L1"] -->|"associated"| ferroptosis["ferroptosis"]
ATG16L1["ATG16L1"] -->|"regulates"| LC3["LC3"]
ATG16L1["ATG16L1"] -->|"interacts"| Cancer["Cancer"]
ATG16L1["ATG16L1"] -->|"interacts"| Als["Als"]
ATG16L1["ATG16L1"] -->|"interacts"| Ms["Ms"]
V_ATPase["V-ATPase"] -->|"interacts"| ATG16L1["ATG16L1"]
ZFP36["ZFP36"] -.->|"inhibits"| ATG16L1["ATG16L1"]
OPTN["OPTN"] -->|"interacts"| ATG16L1["ATG16L1"]
CASP3["CASP3"] -->|"regulates"| ATG16L1["ATG16L1"]
style ATG16L1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Autophagy | associated_with | pathway | 1.00 |
| Intestinal Epithelial Barrier Function | regulates | phenotype | 0.95 |
| ATG12-ATG5 CONJUGATE | interacts_with | protein | 0.95 |
| Casm | involved_in | process | 0.90 |
| intestinal epithelial cells | expressed_in | cell_type | 0.90 |
| autophagy | regulates | pathway | 0.90 |
| Crohn's Disease | risk_factor_for | disease | 0.88 |
| Intestinal Disease | associated_with | disease | 0.88 |
| Inflammation | associated_with | disease | 0.85 |
| ATG12-ATG5 | interacts_with | protein | 0.80 |
| ATG12-ATG5-ATG16L1_complex | part_of | protein | 0.80 |
| autophagy pathway | participates_in | pathway | 0.80 |
| ferroptosis | associated_with | pathway | 0.80 |
| Cancer | regulates | disease | 0.75 |
| Tumor | associated_with | disease | 0.75 |
| Infection | activates | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| Bacterial Infection | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| Intestinal Epithelial Barrier | regulates | process | 0.75 |
| AUTOPHAGY | activates | gene | 0.70 |
| Autophagy | regulates | pathway | 0.70 |
| CGAS | activates | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| LAMP1 | activates | gene | 0.70 |
| LC3 | regulates | protein | 0.70 |
| AUTOPHAGY | associated_with | gene | 0.70 |
| ATG7 | associated_with | gene | 0.70 |
| UBIQUITIN | interacts_with | gene | 0.70 |
| Autophagy | expressed_in | pathway | 0.70 |
| AUTOPHAGY | regulates | gene | 0.70 |
| Glioblastoma | activates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Hepatitis | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| Rheumatoid Arthritis | associated_with | disease | 0.65 |
| Epilepsy | regulates | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Autoimmune | inhibits | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Cardiovascular | expressed_in | disease | 0.65 |
| Melanoma | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| V-ATPase | interacts_with | protein | 0.93 |
| V-ATPASE | interacts_with | protein | 0.93 |
| ZFP36 | inhibits | gene | 0.90 |
| STING | interacts_with | protein | 0.85 |
| ATG12-ATG5 | interacts_with | gene | 0.80 |
| ZDHHC7 | associated_with | gene | 0.80 |
| AUTOPHAGY | associated_with | gene | 0.80 |
| ATG14 | associated_with | gene | 0.70 |
| CGAS | activates | gene | 0.70 |
| ATG5 | associated_with | gene | 0.70 |
| LC3 | interacts_with | gene | 0.70 |
| AUTOPHAGY | expressed_in | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| FIP200 | associated_with | gene | 0.70 |
| TLR | activates | gene | 0.70 |
| LC3 | associated_with | gene | 0.70 |
| INFLAMMATION | associated_with | gene | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| AUTOPHAGY | targets | phenotype | 0.65 |
| MAPK14 | interacts_with | gene | 0.60 |
| MLKL | interacts_with | gene | 0.60 |
| TFE3 | interacts_with | gene | 0.60 |
| BECN1 | regulates | gene | 0.60 |
| RPTOR | interacts_with | gene | 0.60 |
| ATG5 | interacts_with | gene | 0.60 |
| ATG5 | activates | gene | 0.60 |
| UBIQUITIN | interacts_with | gene | 0.60 |
| ATG12 | inhibits | gene | 0.60 |
| DLK1 | inhibits | gene | 0.60 |
| TAX1BP1 | associated_with | gene | 0.60 |
| P62 | associated_with | gene | 0.60 |
| ATG13 | associated_with | gene | 0.60 |
| NBR1 | associated_with | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| RB1 | associated_with | gene | 0.60 |
| IFNG | associated_with | gene | 0.60 |
| MAP1LC3A | associated_with | gene | 0.60 |
| CASP1 | associated_with | gene | 0.60 |
| TNF | associated_with | gene | 0.60 |
| TLR4 | associated_with | gene | 0.60 |
| S100A8 | associated_with | gene | 0.60 |
| CASP4 | associated_with | gene | 0.60 |
| BECN1 | expressed_in | gene | 0.60 |
| ATG5 | expressed_in | gene | 0.60 |
| SQSTM1 | expressed_in | gene | 0.60 |
| LAMP1 | expressed_in | gene | 0.60 |
| KAT2B | regulates | gene | 0.60 |
| ATG9A | regulates | gene | 0.60 |
| AMBRA1 | activates | entity | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ATG16L1 in their description or question text
No additional research found